Scale-up diligence for the bioeconomy.
ECBF brings in Scaleflow for product and tech due diligence on its scale-up investments, from virtual fencing to agtech.
ECBF
ECBF invests growth-stage in the circular bioeconomy, where the technology has to deliver on the thesis. Before committing, the fund wants a clear answer to one question: can the technology and the product organisation scale effectively with the plan?
How it went
Product and tech due diligence on live deals
ECBF brings in Scaleflow on its scale-up investments, with the assessment delivered against the deal timeline. Publicly backed deals include Nofence, the Norwegian virtual-fencing pioneer, and Doktar, the agtech platform for sustainable farming.
Technology and organisation in one read
The assessment covers the product and the technology, and the product organisation behind it: can both carry the growth the investment case assumes?
Alongside co-investors
The findings serve the whole syndicate. On Doktar, the round was co-led with impact investor Pymwymic.
“Their technical due diligence supports our scale-up investments by providing a clear assessment of whether the technology and product organization can scale effectively.”
What the due diligence surfaced
- A clear assessment of whether the technology and the product organisation can scale effectively
- The technical risk behind the thesis, framed for the investment decision
- A read that works across very different technologies, from hardware in the field to data platforms
The outcome
- Nofence closed a 30M euro Series B led by ECBF, the largest European agtech round of 2025
- Doktar closed a 7.5M euro round co-led by ECBF and Pymwymic
- A repeat collaboration across deals in the portfolio
ECBF
Venture Capital
The first venture fund exclusively dedicated to accelerating the shift from a fossil-based to a bio-based circular economy.
Start with an X-Ray.
1 business day. The complete picture. 250+ assessments delivered.